Literature DB >> 24631657

Amphiphilic degradable polymers for immobilization and sustained delivery of sphingosine 1-phosphate.

Jing Zhang1, Jie Song2.   

Abstract

Controlled delivery of the angiogenic factor sphingosine 1-phosphate (S1P) represents a promising strategy for promoting vascularization during tissue repair and regeneration. In this study, we developed an amphiphilic biodegradable polymer platform for the stable encapsulation and sustained release of S1P. Mimicking the interaction between amphiphilic S1P and its binding proteins, a series of polymers with hydrophilic poly(ethylene glycol) core and lipophilic flanking segments of polylactide and/or poly(alkylated lactide) with different alkyl chain lengths were synthesized. These polymers were electrospun into fibrous meshes, and loaded with S1P in generally high loading efficiencies (>90%). Sustained S1P release from these scaffolds could be tuned by adjusting the alkyl chain length, blockiness and lipophilic block length, achieving 35-55% and 45-80% accumulative releases in the first 8h and by 7 days, respectively. Furthermore, using endothelial cell tube formation assay and chicken chorioallantoic membrane assay, we showed that the different S1P loading doses and release kinetics translated into distinct pro-angiogenic outcomes. These results suggest that these amphiphilic polymers are effective delivery vehicles for S1P and may be explored as tissue engineering scaffolds where the delivery of lipophilic or amphiphilic bioactive factors is desired.
Copyright © 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amphiphilic copolymer; Angiogenesis; Drug delivery; Sphingosine-1-phosphate; Tissue engineering

Mesh:

Substances:

Year:  2014        PMID: 24631657      PMCID: PMC4041830          DOI: 10.1016/j.actbio.2014.02.051

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  51 in total

Review 1.  Angiogenesis and bone repair.

Authors:  Richard A D Carano; Ellen H Filvaroff
Journal:  Drug Discov Today       Date:  2003-11-01       Impact factor: 7.851

2.  OCCURRENCE OF 2-HYDROXY FATTY ACIDS IN ANIMAL TISSUES.

Authors:  Y KISHIMOTO; N S RADIN
Journal:  J Lipid Res       Date:  1963-04       Impact factor: 5.922

Review 3.  Vascularized bone tissue engineering: approaches for potential improvement.

Authors:  Lonnissa H Nguyen; Nasim Annabi; Mehdi Nikkhah; Hojae Bae; Loïc Binan; Sangwon Park; Yunqing Kang; Yunzhi Yang; Ali Khademhosseini
Journal:  Tissue Eng Part B Rev       Date:  2012-09-04       Impact factor: 6.389

4.  Controlled growth factor delivery for tissue engineering.

Authors:  Prakriti Tayalia; David J Mooney
Journal:  Adv Mater       Date:  2009-09-04       Impact factor: 30.849

Review 5.  Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes.

Authors:  Matthias W Laschke; Yves Harder; Michaela Amon; Ivan Martin; Jian Farhadi; Andrej Ring; Nestor Torio-Padron; René Schramm; Martin Rücker; Dominic Junker; Jörg M Häufel; Carlos Carvalho; Michael Heberer; Günter Germann; Brigitte Vollmar; Michael D Menger
Journal:  Tissue Eng       Date:  2006-08

Review 6.  Endothelialization approaches for viable engineered tissues.

Authors:  Silvia Baiguera; Domenico Ribatti
Journal:  Angiogenesis       Date:  2012-09-26       Impact factor: 9.596

7.  The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720.

Authors:  Caren E Petrie Aronin; Soo J Shin; Kimberly B Naden; Peter D Rios; Lauren S Sefcik; Sarah R Zawodny; Namory D Bagayoko; Quanjun Cui; Yusuf Khan; Edward A Botchwey
Journal:  Biomaterials       Date:  2010-09       Impact factor: 12.479

Review 8.  Biomaterial delivery of morphogens to mimic the natural healing cascade in bone.

Authors:  Manav Mehta; Katharina Schmidt-Bleek; Georg N Duda; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

9.  Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice.

Authors:  Xun Qi; Yasuo Okamoto; Tomomi Murakawa; Fei Wang; Osamu Oyama; Ryunosuke Ohkawa; Kazuaki Yoshioka; Wa Du; Naotoshi Sugimoto; Yutaka Yatomi; Noriko Takuwa; Yoh Takuwa
Journal:  Eur J Pharmacol       Date:  2010-03-03       Impact factor: 4.432

10.  Delivery of S1P receptor-targeted drugs via biodegradable polymer scaffolds enhances bone regeneration in a critical size cranial defect.

Authors:  Anusuya Das; Shaun Tanner; Daniel A Barker; David Green; Edward A Botchwey
Journal:  J Biomed Mater Res A       Date:  2013-10-17       Impact factor: 4.396

View more
  5 in total

1.  Alginate hydrogels of varied molecular weight distribution enable sustained release of sphingosine-1-phosphate and promote angiogenesis.

Authors:  Priscilla A Williams; Kevin T Campbell; Eduardo A Silva
Journal:  J Biomed Mater Res A       Date:  2017-09-26       Impact factor: 4.396

2.  Biodegradable PEG-Based Amphiphilic Block Copolymers for Tissue Engineering Applications.

Authors:  Artem B Kutikov; Jie Song
Journal:  ACS Biomater Sci Eng       Date:  2015-05-26

Review 3.  Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.

Authors:  Ziad Sartawi; Ernestina Schipani; Katie B Ryan; Christian Waeber
Journal:  Pharmacol Res       Date:  2017-09-22       Impact factor: 7.658

4.  Synthesis and characterization of 3-methyl-6-[(propyn-yloxy)meth-yl]-1,4-dioxane-2,5-dione.

Authors:  Igor Elkin; Thierry Maris; Patrice Hildgen
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-06-16

5.  Impaired osteogenesis of T1DM bone marrow-derived stromal cells and periosteum-derived cells and their differential in-vitro responses to growth factor rescue.

Authors:  Tera M Filion; Jordan D Skelly; Henry Huang; Dale L Greiner; David C Ayers; Jie Song
Journal:  Stem Cell Res Ther       Date:  2017-03-11       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.